![Michael Nohaile](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 541 208 $ in data 30/09/2026
Michael Nohaile is Chief Executive Officer at Prellis Biologics, Inc. since 2022 and Independent Director at Fulgent Genetics, Inc. since 2022.
Former roles include Director at Genoptix, Inc., General Manager-Molecular Diagnostics Business at Novartis Corp.
from 2007 to 2012, Partner at McKinsey & Co., Inc. from 2000 to 2007, Senior VP-Strategy, Commercialization & Innovation at Amgen, Inc. from 2012 to 2021, Global Head-Molecular Diagnostics at Novartis AG from 2008 to 2012, and Chief Scientific Officer at Generate Biomedicines, Inc. from 2021 to 2022.
Education includes undergraduate studies at Massachusetts Institute of Technology and a doctorate from the University of California, Berkeley.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 14/05/2026 | 24.578 ( 0,08% ) | 541 208 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| FULGENT GENETICS, INC. | Direttore/Membro del Consiglio | 01/08/2022 |
Prellis Biologics, Inc.
 Prellis Biologics, Inc. BiotechnologyHealth Technology Develops novel technology to bio print vascularized human tissues | Amministratore Delegato | 11/08/2022 |
| Società | Posizione | Fine |
|---|---|---|
| GENERATE BIOMEDICINES, INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2022 |
| AMGEN INC. | Corporate Officer/Principal | 01/02/2021 |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Corporate Officer/Principal | 01/11/2012 |
| NOVARTIS AG | Corporate Officer/Principal | 01/11/2012 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | 01/01/2007 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genoptix, Inc.
 Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services | Health Services |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fulgent Genetics, Inc.
 Fulgent Genetics, Inc. Medical/Nursing ServicesHealth Services Provides genetic diagnostics services | Health Services |
Prellis Biologics, Inc.
Prellis Biologics, Inc. BiotechnologyHealth Technology Develops novel technology to bio print vascularized human tissues | Health Technology |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. BiotechnologyHealth Technology Operates as a clinical-stage generative biology company that provides biotechnology and drug design & development services | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
